Zydus Wellness Net Profit rises 11 pc to Rs 69.10 crore in Q4

As per the MAT March''20 report of Nielsen, Glucon-D, Nycil, Everyuth Scrub and Everyuth Peel Off Mask continued to hold the number one position

Published On 2020-06-03 04:15 GMT   |   Update On 2021-08-10 11:27 GMT
Advertisement

New Delhi: Zydus Wellness on Tuesday reported a 10.89 percent rise in consolidated net profit to Rs 69.10 crore for the quarter ended on March 31, 2020.

The company had posted a net profit of Rs 62.31 crore for the corresponding period of 2018-19, Zydus Wellness said in a BSE filing.

The total revenue of the company stood at Rs 489.17 crore for the quarter under consideration. It was Rs 424.64 crore for the same period year ago, it added.

Advertisement

Net profit for the financial year 2019-20 was at Rs 141.72 crore as against Rs 169.14 crore in previous fiscal, Zydus Wellness said.

The company's revenue for FY20 stood at Rs 1,777.53 crore. It was Rs 881.70 crore for FY19, it added.

"As per the MAT March''20 report of Nielsen, Glucon-D, Nycil, Everyuth Scrub and Everyuth Peel Off Mask continued to hold the number one position. Glucon-D holds a market share of 59 percent and Nycil has a market share of 34.4 percent," Zydus Wellness said.

Everyuth Scrub and Everyuth Peel Off Mask continue to lead in their segments with a market share of 32.5 percent, and 77.9 percent respectively, it added.

Shares of Zydus Wellness were trading at Rs 1,313.05 per scrip on the BSE, up 4.04 percent over the previous close. 

Read also: Zydus Cadila supplies 30,000 COVID Kavach Elisa test kits to ICMR for free


Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News